RAC 0.00% $1.55 race oncology ltd

Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-58

  1. 1,021 Posts.
    lightbulb Created with Sketch. 11294
    Good post, my man.

    What I would say is that the clinical history for Bisantrene easily warrants a $2B AUD MC.

    You do not have to look far to see peers were sold for significantly more with considerably less.

    I think you would struggle to find another opportunity as large, derisked, and undervalued on the ASX.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
0.000(0.00%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.55 $1.59 $1.53 $101.1K 64.92K

Buyers (Bids)

No. Vol. Price($)
4 15599 $1.55
 

Sellers (Offers)

Price($) Vol. No.
$1.59 2000 1
View Market Depth
Last trade - 16.10pm 01/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.